Clinical results of IMAT in adenocarcinoma prostate cancer

被引：0
作者：
Gribaudo, S. [1 ]
Monetti, U. [1 ]
Mussano, A. [1 ]
La Sala, S. [1 ]
Di Gregorio, S. [1 ]
Richetto, V. [1 ]
Sardo, A. [1 ]
Trevisiol, E. [1 ]
Madon, E. [1 ]
Urgesi, A. [1 ]
机构：
[1] OIRM, S Anna Hosp, Turin, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2006年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1079
引用
收藏
页码：S440 / S440
页数：1
相关论文
共 50 条
  • [21] Clinical results from first use of prostate stent as fiducial for radiotherapy of prostate cancer
    Carl, Jesper
    Nielsen, Jane
    Holmberg, Mats
    Larsen, Erik Hoejkjaer
    Fabrin, Knud
    Fisker, Rune V.
    ACTA ONCOLOGICA, 2011, 50 (04) : 547 - 554
  • [22] Clinical implementation of intensity modulated arc therapy (IMAT) for rectal cancer.
    Duthoy, W
    De Gersem, W
    Boterberg, T
    Smeets, P
    Peeters, M
    De Neve, W
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 290S - 290S
  • [23] Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: Experimental and clinical results
    Zietman, AL
    Prince, EA
    Nakfoor, BM
    Shipley, WU
    UROLOGY, 1997, 49 (3A) : 74 - 83
  • [24] Prostate Cancer Masquerading as Colon Adenocarcinoma
    Patel, Preet
    Huang, Cheng
    Rosenvinge, Erik C. von
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (06) : XIX - XX
  • [25] Prostate cancer pathologic parameters and clinical outcome: Results from the cooperative prostate cancer tissue resource (CPCTR)
    Melamed, J
    Datta, MW
    Becich, MJ
    Bosland, M
    Dhir, R
    Kajdacsy-Balla, A
    Orenstein, J
    Silver, S
    Berman, JJ
    MODERN PATHOLOGY, 2003, 16 (01) : 162A - 162A
  • [26] Prostate cancer pathologic parameters and clinical outcome: Results from the cooperative prostate cancer tissue resource (CPCTR)
    Melarned, J
    Datta, MW
    Becich, MJ
    Bosland, M
    Dhir, R
    Kajdacsy-Balla, A
    Orenstein, J
    Silver, S
    Berman, JJ
    LABORATORY INVESTIGATION, 2003, 83 (01) : 162A - 162A
  • [27] Oligometastatic Prostate Adenocarcinoma. Clinical-Pathologic Study of a Histologically Under-Recognized Prostate Cancer
    Manini, Claudia
    Gonzalez, Alba
    Buchser, David
    Garcia-Olaverri, Jorge
    Urresola, Arantza
    Ezquerro, Ana
    Fernandez, Iratxe
    Llarena, Roberto
    Zabalza, Inaki
    Pulido, Rafael
    Carracedo, Arkaitz
    Gomez-Iturriaga, Alfonso
    Lopez, Jose I.
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04): : 1 - 9
  • [28] Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer
    Duthoy, W
    De Gersem, W
    Vergote, K
    Boterberg, T
    Derie, C
    Smeets, P
    De Wagter, C
    De Neve, W
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (03): : 794 - 806
  • [29] Clinical implementation of IMAT prostate treatment using Elekta synergy and ERGO++ treatment planning system
    Shiraishi, K.
    Nakagawa, K.
    Haga, A.
    Ohtomo, K.
    Okano, Y.
    Oritate, T.
    Yoda, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S650 - S650
  • [30] A CLINICAL AND IMMUNOHISTOCHEMICAL STUDY OF PAPILLARY ADENOCARCINOMA OF THE PROSTATE
    ITO, T
    FURUSATO, M
    AKIYAMA, A
    KATO, H
    AIZAWA, S
    PROSTATE, 1995, 26 (01) : 23 - 27
12345